ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Antimicrobial activity of bacterial endophytes isolated from Aconitum nagarum Stapf ,a medicinal plant of North East Indo-Burma belt.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study aimed to investigate bacterial endophytes from different tissues of Aconitum nagarum, a threatened and medicinally important plant native to North East India, and to evaluate their antimicrobial potential. A total of 47 bacterial isolates were obtained from leaf, stem, and tuberous root samples, with the highest colonization frequency observed in leaf tissues (32.50%). Based on morphological, microscopic, and biochemical characterization, the isolates were categorized into six bacterial genera: Actinomycetes, Bacillus, Pseudomonas, Serratia, Streptococcus, and Streptomyces. All isolates were screened for antimicrobial activity against a panel of clinically significant pathogens: Pseudomonas aeruginosa (ATCC 9027), Klebsiella pneumoniae (ATCC 1705), Bacillus subtilis (ATCC 6051), and Candida albicans (MTCC 227). Among them, two isolates identified as Bacillus amyloliquefaciens and Bacillus siamensis exhibited significant antimicrobial activity, showing the highest zones of inhibition against K. pneumoniae, ranging from 18.04 ± 0.42 mm to 20.03 ± 0.63 mm. Crude metabolites of these isolates were extracted using ethyl acetate and characterized by GC-MS analysis. GC-MS analysis of B. amyloliquefaciens extracts revealed major compounds such as tetradecanoic acid, 4-tert-amylphenol, pyrrolo[1,2-a] pyrazine-1,4-dione, and benzeneacetic. In contrast, the extracts of B. siamensis contained cyclotrisiloxane, hexamethyl, 3-methylpentanoic acid, 2-methylbutanoic acid and 2-ethylheptanoic acid as principal compounds. While many of these compounds are known for their antimicrobial properties, the bioactivity of some remains to be elucidated. This study highlights the potential of endophytic bacteria from A. nagarum as a promising source of novel antimicrobial metabolites. Further in-depth investigations could lead to the discovery of new bioactive compounds with therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.